Now showing items 1-1 of 1

    • Thumbnail

      RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease 

      Afonso, Marta Bento; Rodrigues, Pedro M.; Mateus Pinheiro, Miguel; Simao, André L.; Gaspar, María M.; Majdi, Amine; Arretxe Oliden, Enara; Alonso, Cristina; Santos Laso, Álvaro; Jiménez Agüero, Raúl; Eizaguirre Letamendia, Emma; Bujanda Fernández de Pierola, Luis ORCID; Pareja Megía, María J.; Bañales Asurmendi, Jesús María ORCID; ratziu, Vlad; Gautheron, Jeremie; Castro, Rui E.; Rodrigues, Cecilia M. P. (BMJ, 2021-12)
      [EN]Objective Receptor-interacting protein kinase 3 (RIPK3) is a key player in necroptosis execution and an emerging metabolic regulator, whose contribution to non-alcoholic fatty liver disease (NAFLD) is controversial. ...